Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Envoy Medical (COCH) Invested Capital (2022 - 2025)

Envoy Medical's Invested Capital history spans 4 years, with the latest figure at -$7.7 million for Q3 2025.

  • For Q3 2025, Invested Capital rose 58.69% year-over-year to -$7.7 million; the TTM value through Sep 2025 reached -$7.7 million, up 58.69%, while the annual FY2024 figure was -$18.8 million, 1186.14% down from the prior year.
  • Invested Capital for Q3 2025 was -$7.7 million at Envoy Medical, up from -$29.9 million in the prior quarter.
  • Across five years, Invested Capital topped out at $5.0 million in Q3 2023 and bottomed at -$47.5 million in Q1 2023.
  • The 4-year median for Invested Capital is -$24.2 million (2025), against an average of -$21.4 million.
  • The largest annual shift saw Invested Capital soared 119.63% in 2023 before it tumbled 1186.14% in 2024.
  • A 4-year view of Invested Capital shows it stood at -$35.9 million in 2022, then skyrocketed by 95.91% to -$1.5 million in 2023, then crashed by 1186.14% to -$18.8 million in 2024, then soared by 59.34% to -$7.7 million in 2025.
  • Per Business Quant, the three most recent readings for COCH's Invested Capital are -$7.7 million (Q3 2025), -$29.9 million (Q2 2025), and -$24.2 million (Q1 2025).